- Home
- ZOOZ vs GDTC Comparison
ZOOZ vs GDTC Comparison
Compare ZOOZ & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZOOZ
- GDTC
- Stock Information
- Founded
- ZOOZ 2013
- GDTC 2018
- Country
- ZOOZ Israel
- GDTC Singapore
- Employees
- ZOOZ N/A
- GDTC N/A
- Industry
- ZOOZ
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- ZOOZ
- GDTC Health Care
- Exchange
- ZOOZ NYSE
- GDTC Nasdaq
- Market Cap
- ZOOZ 24.5M
- GDTC 23.7M
- IPO Year
- ZOOZ N/A
- GDTC 2023
- Fundamental
- Price
- ZOOZ $2.68
- GDTC $2.40
- Analyst Decision
- ZOOZ Strong Buy
- GDTC Buy
- Analyst Count
- ZOOZ 1
- GDTC 1
- Target Price
- ZOOZ $5.00
- GDTC $5.00
- AVG Volume (30 Days)
- ZOOZ 18.4K
- GDTC 22.0K
- Earning Date
- ZOOZ 11-25-2024
- GDTC 01-01-0001
- Dividend Yield
- ZOOZ N/A
- GDTC N/A
- EPS Growth
- ZOOZ N/A
- GDTC N/A
- EPS
- ZOOZ N/A
- GDTC N/A
- Revenue
- ZOOZ $506,656.00
- GDTC $330,254.00
- Revenue This Year
- ZOOZ N/A
- GDTC $14.71
- Revenue Next Year
- ZOOZ $37.50
- GDTC N/A
- P/E Ratio
- ZOOZ N/A
- GDTC N/A
- Revenue Growth
- ZOOZ N/A
- GDTC N/A
- 52 Week Low
- ZOOZ $1.66
- GDTC $1.20
- 52 Week High
- ZOOZ $4.60
- GDTC $5.50
- Technical
- Relative Strength Index (RSI)
- ZOOZ N/A
- GDTC 52.27
- Support Level
- ZOOZ N/A
- GDTC $2.15
- Resistance Level
- ZOOZ N/A
- GDTC $2.60
- Average True Range (ATR)
- ZOOZ 0.00
- GDTC 0.32
- MACD
- ZOOZ 0.00
- GDTC -0.05
- Stochastic Oscillator
- ZOOZ 0.00
- GDTC 30.86
About ZOOZ ZOOZ POWER LTD
Zooz Power Ltd is a provider of Flywheel-based Power Boosting solutions enabling widespread deployment of ultra-fast charging infrastructure for electric vehicles (EV) while overcoming existing grid limitations. ZOOZ pioneers its flywheel-based power boosting technology, enabling efficient utilization and power management of a power-limited grid at an EV charging site. Its Flywheel technology allows high-performance, reliable, and cost-effective ultra-fast charging infrastructure. ZOOZ Power's sustainable, power-boosting solutions are built with longevity and the environment in mind, helping its customers and partners accelerate the deployment of fast-charging infrastructure, thus facilitating improved utilization rates, efficiency, and greater flexibility.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.